May 17 (Reuters) - Zosano Pharma Corp :
* EMERGEX VACCINES ANNOUNCES SUCCESSFUL COATING OF ITS NOVEL CD8+ T CELL ADAPTIVE COVID-19 VACCINE ONTO ZOSANO PHARMA'S MICRO-NEEDLE PATCH
* EMERGEX - CO, ZOSANO HAVE SHOWED CO'S COVID-19 VACCINE IS STABLE ON PATCHES OVER A WIDE TEMP RANGE FOR UP TO 6 MONTHS AT 40$(O)$C/75% RELATIVE HUMIDITY
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))